California and a handful of other states will probably vote on legal pot in 2016. Whether it passes will depend on the quality of the proposal, how much money is involved in the campaigns, and how things play out in Colorado, Washington, and other places that have legalized production and sales.
Welcome to the RAND Drug Policy Research Center
Providing decisionmakers with rigorous, nonpartisan research on substance use and drug policy
Since 1989, the RAND Drug Policy Research Center has conducted research to help decisionmakers in the United States and throughout the world address issues involving alcohol and other drugs. In doing so, the Center brings an objective and data-driven perspective to this often emotional and fractious policy arena.
DPRC in the News
A selection of news reporting on critical RAND Drug Policy Research Center research and commentary.
- 'Hay Que Ser Flexibles en Política De Drogas' ("We Must Be Flexible in Drug Policy") (El Espectador)
- Florida’s Amendment 2 Insults Our Intelligence (Flcourier.com)
- Faster Justice, Closer: The Power of Community Courts (Pacific Standard)
- Poll: Vermont Voters Split on Marijuana Legalization (WCAX)
- Buprenorphine Use Remains Hit or Miss (Behavioral Healthcare)
- RAND: State Policies to Tackle Heroin Addiction (POLITICO)
- Hardly Anyone Uses Heroin. So Why Do We Keep Freaking Out About It? (Wonkblog - The Washington Post)
- 24 Maps and Charts That Explain Marijuana (Vox)
- Study Looks at Marijuana Market (WPTZ-TV)
- The Threat of Commercialized Marijuana (Vox)
From the RAND Blog
Implementation of Medical Marijuana and Its Impact on Health
Few studies have considered how medical marijuana policies affect recreational marijuana use or individual and public health outcomes, and the few published quantitative studies on the topic find disparate results. This NIH/NIDA-funded project will systematically code medical marijuana policies at the state level into a database, paying careful attention to issues related to access and supply. The data, once completed, will be made available to other researchers.
Adolescent Alcohol and Drug Use Trajectories: The Role of Race and Ethnicity
This health promotion and disease prevention project will measure youth alcohol and drug use annually in a racially and ethnically diverse sample of middle school and high school students.
Preventing and Managing Prescription Drug Misuse Among Military Personnel
To estimate the potential burden that prescription drug misuse poses to the military and identify promising practices to prevent and treat prescription drug misuse.
Treating Depression in People with Substance Abuse Problems
Building Recovery by Improving Goals, Habits, and Thoughts (BRIGHT) is a group cognitive behavioral therapy, or CBT, to treat depression in people with substance abuse problems.
Analyzing the Illicit Drug Market in the EU
To further analyze Europe's illicit drug market and the EU's responses to it, DPRC and RAND Europe are teaming with European partners to expand their original 2009 research on the global drug market.
Evaluating the Causal Pathways from Lapse to Relapse in Smokers
The goal of this project is to uncover the psychological variables that cause smokers to relapse. The results will be used to inform a new generation of more successful smoking cessation treatments.
Measuring Drug Related Crime
RAND was awarded a contract to develop a methodology for the Office of National Drug Control Policy (ONDCP) to estimate drug-related crimes in the United States and to pilot test the proposed methodology using a select number of data sources to develop estimates at the national level.
Evaluating the Efficacy of Social Impact Bonds to Reduce Criminal Recidivism
RAND Europe has been commissioned to evaluate the development, implementation and operation of this first ever Social Impact Bond.